Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metcalf, D.
Right arrow Articles by Di Rago, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metcalf, D.
Right arrow Articles by Di Rago, L.

Stem Cells 2002;20:460-469 www.StemCells.com
© 2002 AlphaMed Press

Stem Cell Factor Can Stimulate the Formation of Eosinophils by Two Types of Murine Eosinophil Progenitor Cells

Donald Metcalf, Sandra Mifsud, Ladina Di Rago

Division of Cancer and Hematology, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Key Words. Eosinophil formation • Culture • Mouse • Stem cell factor

Donald Metcalf, M.D., Division of Cancer and Hematology, The Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Victoria 3050 Australia. Telephone: 61-3-9345-2555; Fax: 61-3-9347-0852; e-mail: metcalf{at}wehi.edu.au


    ABSTRACT
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
There are only three known stimuli for eosinophil formation—GM-CSF, interleukin-5 (IL-5), and IL-3. Because mice with inactivation of the gene encoding the common ß receptor chain for GM-CSF, IL-5, and IL-3 (ßc-/- mice) cannot respond to GM-CSF or IL-5 and do not produce IL-3, they should lack eosinophils. However, they produce reduced numbers of eosinophils, indicating the existence of at least one additional stimulatory factor. Use of ßc-/- mouse marrow cells failed to detect a novel eosinophil-stimulating factor in cell line- or organ-conditioned media, but stem cell factor (SCF) was found to have a previously unrecognized ability to stimulate the formation of eosinophil colonies or mixed neutrophil-eosinophil colonies. This action of SCF was also observable with marrow cells from other mouse strains and was enhanced by the addition of G-CSF but no other factor tested. Recloning of SCF-stimulated blast colonies showed that progenitors forming pure eosinophil or mixed neutrophil-eosinophil colonies can have a common ancestor but many appear to arise independently from different preprogenitor cells. The observed activity of SCF in marrow cultures was relatively weak, but its action may be stronger in vivo, and SCF needs to be added to GM-CSF, IL-5, and IL-3 in the list of cytokines able to stimulate eosinophil formation.


    INTRODUCTION
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previous studies on clonal cultures of murine marrow cells have documented only three growth factors—interleukin-3 (IL-3), GM-CSF, and IL-5—as being able to stimulate eosinophil colony formation [1–3]. Gene inactivation studies have shown that IL-5 is quantitatively the most active of the three in determining levels of eosinophils in the marrow and blood [4–6]. Marrow cells from mice with homozygous deletion of the gene encoding the ß common receptor chain shared by GM-CSF, IL-3, and IL-5 cannot respond to attempted stimulation by IL-5 or GM-CSF but can respond in vitro to IL-3 because of the existence on murine cells of an additional, and preferred, ß receptor chain subunit, specific for IL-3 [7]. However, previous studies have failed to document, by polymerase chain reaction analysis, the transcription of IL-3 mRNA in normal mouse organs or, by bioassay, the ability of mouse organs to produce biologically active IL-3 in culture [8].

Based on these considerations, mice with inactivation of the gene encoding the ß common receptor chain (ßc-/- mice) have no known agent able to stimulate eosinophil proliferation and should, therefore, lack eosinophils. ßc-/- mice do exhibit significantly fewer eosinophils in the blood than control mice, but there is not a complete absence of such cells [5]. Furthermore, immature and mature eosinophils are present in the ßc-/- bone marrow, albeit at reduced levels, and mature eosinophils can be found in those tissues, such as the uterus, that usually contain eosinophils. These data have been supported by observations on continuing low-level production of eosinophils in mice with inactivation both of the ßc gene and the gene for IL-3 [9]. The conclusion is that at least one additional eosinophil-stimulating factor must exist and be responsible for stimulating the low level of the eosinophil formation occurring in ßc-/- and ßc-/- IL-3-/- mice.

Because IL-3-responsive eosinophil progenitor cells are present in ßc-/- marrow populations [5], IL-3 can be used as a positive stimulus to verify their presence in each ßc-/- marrow cell suspension used. These cells can then be used to search for novel eosinophil-active factors, particularly in organ-conditioned media, because such media lack IL-3 [8]. The cells can also be used to test the activity of known cytokines with the confidence that any observed eosinophil stimulation cannot be indirectly mediated by the induced production either of GM-CSF or IL-5.

To date, only a single type of lineage-committed eosinophil progenitor cell has been described that is able to generate colonies of maturing eosinophils (Eo colonies [10]). However, as the present studies progressed, it became obvious that an additional type of committed progenitor cell exists in the mouse that is able to generate colonies containing exclusively neutrophilic granulocytes and eosinophils (GEo colonies). From these studies, it has emerged that stem cell factor (SCF) is an additional regulator with an ability to stimulate the formation of eosinophils by both types of eosinophil progenitor cells.


    MATERIALS AND METHODS
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice
The production and characteristics of ß common chain knockout mice have been described elsewhere [5]. These ßc-/- and control ßc+/+ littermate mice were housed under protected conditions and were monitored regularly for the presence of pathogens. Other mice used were 6- to 8-week-old C57BL/6, BALB/c, and DBA2 mice bred and held under similar conditions. For special experiments, cells were harvested from 16-day fetal liver and the marrow of 7-day-old neonatal C57BL mice.

Marrow Cultures
Agar cultures of bone marrow cells were performed containing from 25,000-500,000 cells per ml in Dulbecco’s modified Eagle’s medium containing a final concentration of 20% (volume by volume) newborn calf serum and 0.3% agar [11]. The 1-ml agar cultures were prepared in 35-mm plastic Petri dishes, and stimuli for colony formation were added in 0.1 ml volumes before the addition of the agar medium containing the target bone marrow cells. After gelling, cultures were incubated for 7 days at 37°C in a fully humidified atmosphere of 10% CO2 in air. After incubation, colony counts were performed at 35x magnification using an Olympus dissection microscope (Olympus; Tokyo, Japan; http://www.olympus.com) then all cultures were fixed by the addition of 1 ml of 2.5% glutaraldehyde. After fixation for 4 hours, intact gels were floated onto glass slides and, after drying, were stained with acetylcholinesterase then Luxol Fast Blue (to identify eosinophils) and counterstained with hematoxylin. Coverslips were mounted using mounting medium, then all colonies present in each culture were enumerated and their cellular composition determined at 100x or 200x magnification. Previous studies have documented that Luxol Fast Blue positivity (green stain) is specific for colony eosinophils [10], and the segmented ring shape of the nucleus in hematoxylin-stained preparations is equally specific for mature neutrophilic granulocytes (granuloctyes).

Stimuli
Media were harvested from cultures of continuous cell lines at confluence or from cultures of minced organs incubated for up to 4 days in serum-free medium as described previously [8,12]. After millipore filtration, 0.1-ml volumes were added to duplicate marrow cultures at 1:1 and 1:2 dilutions.

The final concentration in the cultures of the purified recombinant growth factors tested were: murine GM-CSF, human G-CSF, murine macrophage (M-CSF), murine IL-3 (10 ng/ml), murine IL-6 (100 ng/ml), murine SCF (100 ng/ml), murine flk-ligand (500 ng/ml), human IL-1 (10 U/ml), murine IL-4 (10 ng/ml), murine IL-5 (10 ng/ml), murine thrombopoietin (TPO) (50 ng/ml), human IL-11 (10 ng/ml), murine leukemia inhibitory factor (10 ng/ml), human erythropoietin (Epo) (2 U/ml), murine eotaxin (200 ng/ml), murine interferon {gamma} (2 x 103 U/ml), human oncostatin M (100 ng/ml), and human IL-2 (100 U/ml). All recombinant materials were either produced in this laboratory or purchased from Pepro Tech (Rocky Hill, NJ; http://www.peprotech.com).

Microwell Assays
The Ba/F3 cell line used for the specific bioassay of IL-3 responds by proliferation in microwell cultures to concentrations of IL-3 as low as 1.5 pg/ml [12,13]. For the specific assay of G-CSF or M-CSF, stable Ba/F3 sublines expressing inserted murine G-CSF or M-CSF receptors (Ba/F3GR and Ba/F3MR cell lines) were used, as previously described [13]. Because no organ-conditioned medium in fact contained detectable IL-3, these cell lines were able to provide specific assays for their respective ligands and were able to detect concentrations as low as 100 pg/ml for G-CSF and M-CSF.

The FDC-P1 cell line proliferates in response to both GM-CSF and IL-3 [13]. Because of the absence of IL-3 from organ-conditioned media, the FDC-P1 cell line was able to be used as a specific bioassay for GM-CSF (lower detection limit, 100 pg/ml) [12].

Cell lines for use in microwell assays were washed three times by centrifugation in 10 ml of medium to remove the CSF used in the maintenance cultures. Microwell assays were performed as described previously [12]. All assays included a titration of 1 ng/ml IL-3 to certify the viability and responsiveness of the Ba/F3, Ba/F3GR, and Ba/F3MR cell lines and also a titration of the appropriate purified recombinant regulator starting with an initial concentration of 100 ng/ml for G-CSF and M-CSF. For FDCP-1 cells, the standard titrated was 1 ng/ml GM-CSF.

Recloning Experiments
Cultures of 25,000 C57BL bone marrow cells were stimulated by 100 ng SCF or 100 ng SCF plus 10 ng IL-3. After 7 days of incubation, sequential individual multicentric blast cell colonies were removed using a fine pipette and resuspended in 8 ml of agar medium. One-ml volumes of this suspension of colony cells were recultured using 0.1 ml of pokeweed mitogen-stimulated BALB/c spleen-conditioned medium [11] as a source of GM-CSF and IL-3. After 7 days of incubation, the secondary cultures were fixed, stained, and scored for colony formation as above.


    RESULTS
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ßc-/- marrow cells cannot respond either to GM-CSF or IL-5 [5], and because IL-3 is not detectable in vivo [8], there is no recognized agent that would be able to stimulate eosinophil proliferation in ßc-/- mice. Young adult ßc-/- mice have very low, but not zero, eosinophil levels in their peripheral blood [5]. Moreover, as shown in Table 1Go, the young adult ßc-/- marrow contains both eosinophilic myelocytes and mature eosinophils, although in lower combined numbers than ßc+/+ marrow. Unlike the situation in op/op mice, lacking M-CSF, where the macrophage deficiency is corrected with increasing age [14], an analysis of 8-month-old ßc-/- mice showed no change from the situation shown in Table 1Go for younger ßc-/- mice (data not shown). The presence of some eosinophils in ßc-/- mice indicates that there must be one or more unrecognized agents in the mice that have some ability to stimulate eosinophil proliferation.


View this table:
[in this window]
[in a new window]
 
Table 1. Femoral marrow cellularity ßc-/- versus ßc+/+ mice
 
Screening of Conditioned Media
In an initial search for an eosinophil-active factor, media from cell lines and organ-conditioned media were tested on ßc-/- marrow cells for their ability to stimulate eosinophil colony or cluster formation or even the survival of single eosinophils. Three hundred and eight conditioned media from a variety of murine neoplastic and non-neoplastic cell lines were assayed in cultures of 25,000 ßc-/- bone marrow cells. Cell lines surveyed included stromal cell lines, fibroblast, and carcinoma cell lines as well as a variety of immortalized or transformed hematopoietic cell lines. Two hundred of these were found to stimulate granulocyte and/or macrophage colony formation but, excluding those containing IL-3, as determined by parallel assays on Ba/F3 cells, none stimulated the formation of eosinophil-containing colonies or clusters. The granulocyte and macrophage colony-stimulating activity of active-conditioned media correlated with their content of G-CSF and/or M-CSF, as determined by specific cell line assays.

A similar negative outcome was obtained when organ-conditioned media prepared from C57BL, ßc-/-, or ßc+/+ thymus, heart, lung, salivary gland, spleen, kidney, pancreas, muscle, bladder, bone shaft, or bone marrow tissues were assayed on ßc-/- marrow cells. Many of these organ-conditioned media stimulated granulocyte and/or macrophage colony formation, correlating with their content of G-CSF and M-CSF, but no eosinophil colonies were observed. Parallel assays of the ßc-/- and ßc+/+ organ-conditioned media on Ba/F3 cells failed to detect IL-3 (Table 2Go), eliminating the possibility that tissues in ßc-/- mice had acquired an aberrant capacity to produce IL-3. The content of GM-CSF, G-CSF, and M-CSF in media conditioned by ßc-/- organs did not differ substantially from that of media conditioned by ßc+/+ organs (Table 2Go).


View this table:
[in this window]
[in a new window]
 
Table 2. Total cytokine production in vitro by organs from ßc-/- and ßc+/+ mice
 
Because a possible cellular source of an eosinophil-stimulating factor in ßc-/- mice was within the marrow population itself, an attempt was made to detect such an endogenous factor by crowding of marrow cell cultures. As shown in Table 3Go, cell crowding of both ßc-/- and ßc+/+ cells did result in some endogenously stimulated granulocyte and macrophage colony formation but no eosinophil colonies were observed in cultures of ßc-/- cells.


View this table:
[in this window]
[in a new window]
 
Table 3. Endogenous stimulation of colony formation in cultures of bone marrow cells by progressive crowding
 
Assay of Specific Growth Factors
Using cultures of ßc-/- marrow cells, various purified recombinant cytokines were tested for their ability to stimulate eosinophil proliferation. Those tested were IL-1, IL-2, IL-4, IL-6, IL-7, IL-11, M-CSF, G-CSF, Epo, TPO, Flk-ligand, leukemia inhibitory factor, oncostatin-M, interferon {gamma}, tumor necrosis factor, epidermal growth factor and, importantly, the eosinophil chemotactic agent, eotaxin. None of these had eosinophil stimulating activity at the concentrations tested. However, one agent was found to have such activity—SCF.

SCF-Stimulated Eosinophil Colonies
SCF stimulates the formation of two dominant colony types in cultures of mouse bone marrow cells—blast cell colonies and neutrophilic granulocytic colonies [15]. The compact nature of these colonies made it easier to recognize the additional presence in SCF-stimulated cultures of far less frequent eosinophil-containing colonies. Only approximately 1 in 100 colonies developing in such cultures contained eosinophils. These eosinophil-containing colonies were of two types: compact colonies composed entirely of eosinophils (Eo colonies) and colonies with a dominant population of neutrophilic granulocytes but also containing a minority population of mature eosinophils (GEo colonies)—the eosinophils being distinguishable from neutrophilic granulocytes by their green cytoplasm and nonsegmented nuclei (Fig. 1Go).



View larger version (95K):
[in this window]
[in a new window]
 
Figure 1. SCF-stimulated mixed neutrophilic-eosinophilic colonies. Three mixed neutrophilic-eosinophilic (GEo) colonies showing admixture of green-staining eosinophils (heavy arrows) with mature neutrophils (light arrows). Staining Luxol-Fast-Blue/hematoxylin.

 
A reanalysis of C57BL marrow cultures stimulated by IL-3 or GM-CSF showed that both eosinophil colony types developed, with Eo being more numerous than GEo colonies. Cultures stimulated by IL-5 developed, with few exceptions, compact colonies composed wholly of eosinophils (Table 4Go). In cultures stimulated by G-CSF, no eosinophil-containing colonies developed, regardless of colony size. More intriguingly, as shown in the pooled data in Table 4Go, in 10 independent experiments using C57BL bone marrow, the combination of G-CSF with IL-5 was not synergistic for colony number or size and did not significantly stimulate the formation of GEo colonies—either in the form of granulocytes in eosinophil colonies or eosinophils in granulocytic colonies. No colonies resembling those in Figure 1Go were seen, and in most cases, the colonies scored as GEo were highly dispersed colonies of mature granulocytes in which one, or at most two, mature eosinophils were present. In most cultures, the frequency of these single eosinophils was similar in colony-free areas of the agar, and most of the cells appeared to have been IL-5-activated eosinophils surviving from the initial marrow cells cultured. SCF, therefore, was exceptional in that it was the only eosinophil-active factor stimulating the formation predominantly of GEo colonies.


View this table:
[in this window]
[in a new window]
 
Table 4. Failure of the combination of G-CSF with IL-5 to significantly stimulate GEo colony formation
 
The pure Eo colonies stimulated by SCF were slightly smaller than those stimulated by IL-5 and much smaller than those stimulated either by GM-CSF or IL-3. Similarly, SCF-stimulated GEo colonies contained far fewer eosinophils than did GEo colonies stimulated by GM-CSF or IL-3. In SCF-stimulated cultures, GEo colonies tended to be of small to medium size, and eosinophils were never seen either in blast or large multicentric granulocytic colonies. Where other colony types were present, as in cultures stimulated by GM-CSF or IL-3, it was notable that eosinophils never developed in granulocyte-macrophage colonies, macrophage, megakaryocyte, or erythroid colonies.

Enhancement of SCF Action by G-CSF
Figure 2Go presents data from four separate experiments in which cultures of 100,000 ßc-/- marrow cells were compared with paired cultures of 100,000 ßc+/+ marrow cells. The figure shows the mean number of Eo and GEo colonies developing in duplicate cultures stimulated either by SCF, SCF plus G-CSF, or IL-3. The data make several points of interest. Of necessity, the content of eosinophil progenitors can only be assessed in ßc-/- marrow by the use of IL-3. With this as the standard stimulus, it was clear that ßc-/- marrow does contain eosinophil progenitor cells, although in slightly lower frequency than in the ßc+/+ marrow. For both marrow types, when stimulated by IL-3, Eo colonies outnumbered GEo colonies. SCF stimulated eosinophil colony formation by both ßc-/- and ßc+/+ marrow cells. The numbers of colonies developing were small and GEo tended to be the more common colony type. Addition of G-CSF to SCF not only greatly enhanced the size of blast and granulocytic colonies in the cultures, as previously described [16], but also reproducibly increased the number of eosinophil-containing colonies, although the magnitude of the change was less than that for blast or granulocytic colonies. It was a surprising, but consistent, observation that the combination of SCF with G-CSF enhanced Eo colony formation more than GEo, and numbers of the latter type actually fell in many experiments using the combined stimulus.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 2. Stimulation of eosinophil colonies by SCF is enhanced by G-CSF. Number of eosinophil colonies developing in cultures of 105 ßc-/- or ßc+/+ marrow cells in four replicate experiments (1-4). Each column represents mean data from two replicate cultures. Open column = number of pure eosinophil colonies. Black part of column = number of neutrophil-eosinophil (GEo) colonies.

 
A similar pattern of eosinophil colony formation was seen in SCF-stimulated cultures of C57BL, DBA2, and BALB/c adult bone marrow cells and was seen also in cultures of neonatal C57BL bone marrow cells and C57BL 16-day fetal liver cells (data not shown).

The low frequency of SCF-responsive eosinophil progenitors made it impractical to attempt single-cell cultures or clone transfer experiments to verify a direct action of SCF on the clonogenic cells. However, in experiments varying the numbers of cultured C57BL marrow cells from 10,000 to 200,000 per culture, eosinophil colony formation was linear with cultured cell numbers (data not shown).

Enhancement of SCF-stimulated blast and granulocytic colony formation comparable with that elicited by G-CSF can also be elicited by the addition of IL-6 [17]. However, as shown by the representative experiment in Figure 3Go, combination of IL-6 with SCF did not enhance eosinophil colony formation. Similarly, although combination of Epo or TPO with SCF enhanced megakaryocyte colony formation, the combination did not modify SCF-stimulated eosinophil colony formation. Combination of SCF with all the remaining cytokines listed above, except GM-CSF or IL-3, also failed to enhance SCF-stimulated eosinophil colony formation. G-CSF, therefore, appeared to play a special role in being able to enhance SCF-stimulated eosinophil colony formation.



View larger version (11K):
[in this window]
[in a new window]
 
Figure 3. IL-6 is unable to enhance eosinophil colony formation stimulated by SCF. Number of eosinophil colonies developing in cultures of 105 C57BL marrow cells. Each column represents mean data from duplicate cultures. Open column = number of pure eosinophil colonies. Black part of column = number of neutrophil-eosinophil (GEo) colonies.

 
Eosinophil Progenitor Cells in SCF-Stimulated Blast Colonies
SCF-stimulated blast colonies are clonal populations of committed progenitor cells derived from individual preprogenitor cells. To determine whether Eo progenitor cells are ancestrally related to GEo progenitor cells, studies were performed on SCF-stimulated C57BL-marrow-derived multicentric blast colonies [16,17]. Individual 7-day blast colonies were resuspended in agar medium then recultured in replicate cultures stimulated by pokeweed mitogen-stimulated spleen-conditioned medium as a source of GM-CSF and IL-3. The blast colonies used had been stimulated to develop by SCF alone or SCF plus IL-3, the latter combination having been shown in previous studies not only to increase blast colony size and progenitor cell content, but also to increase the frequency of eosinophil-committed progenitor cells [16]. After 7 days of incubation, the secondary cultures were fixed and analyzed for their content of colonies.

None of the 113 blast colonies analyzed were composed solely of Eo or GEo progenitors. Blast colonies contained progenitors able to form granulocytic, granulocyte-macrophage, macrophage, or eosinophil-containing colonies, although not all colonies contained progenitors of all types. As noted in earlier studies, the absolute number of progenitor cells in individual colonies varied widely [16,18]. Furthermore, as in primary marrow cultures, no eosinophils were observed in secondary macrophage or granulocyte-macrophage colonies.

The calculated total content of granulocytic progenitor cells for 113 individual blast colonies comparing those containing eosinophil progenitors with those lacking these progenitors is shown in Figure 4Go. The content of granulocytic progenitors varied from 0 to 1,406 per colony, and progenitor numbers were higher where colony size had been enhanced by combination of IL-3 with SCF. Where blast colonies contained eosinophil progenitors, these were approximately tenfold less numerous than granulocytic progenitors in the colony, and Eo progenitors were present in only 24 of 113 colonies analyzed. As shown previously [16], eosinophil progenitors were more often present in blast colonies when IL-3 had been combined with SCF, and there was a weak association between the occurrence of Eo progenitors and overall total granulocytic progenitor cell numbers.



View larger version (11K):
[in this window]
[in a new window]
 
Figure 4. Only a minority of blast colonies contain eosinophil progenitor cells. Calculated total number of neutrophilic granulocyte progenitor cells in 113 7-day C57BL blast colonies initiated by SCF ({bullet}) or SCF plus IL-3 ({circ}) grouped according to whether or not the colony also contained Eo or GEo progenitor cells. Note that most colonies containing Eo or GEo progenitors had been initiated by SCF plus IL-3.

 
As also shown in Figure 4Go, blast colonies containing GEo progenitors were even less frequent than those containing Eo progenitor cells, and only 10 of 113 colonies analyzed contained GEo progenitor cells. The occurrence of GEo progenitors was significantly associated with a high colony content of granulocytic progenitors ({chi}2 = 8.8), and GEo progenitors were more common in blast colonies stimulated by SCF plus IL-3 than in colonies stimulated only by SCF.

A comparative analysis of blast colony content of macrophage progenitors and either Eo or GEo progenitors showed less evident associations (data not shown), and in fact, 9 of the 24 blast colonies containing eosinophil progenitors contained no macrophage progenitor cells.

Figure 5Go provides an analysis of the numbers of Eo or GEo progenitors in blast colonies containing one or both cell types. Eo progenitors were, in general, somewhat more numerous in positive colonies than GEo progenitors. Two points emerged from this analysis of relevance to the possible ancestral relationship between GEo and Eo progenitors. First, in 19 of the 26 blast colonies, only one type of eosinophil progenitor cell was present. Second, 16 of the 26 blast colonies contained Eo but not GEo progenitor cells. Both observations argue against the possibility that GEo might be the ancestors of the Eo progenitors. There were, however, 7 of 26 colonies that did contain both types of eosinophil progenitors and, at least for these, a common ancestor (blast colony-forming cell) has therefore been documented. This still leaves open the possibility that many Eo and GEo may be derived independently from possibly differing preprogenitor (blast colony-forming) cells.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 5. Occurrence of eosinophil progenitors in blast colonies. Calculated total number of eosinophil progenitor cells (Eo) and neutrophil-eosinophil progenitor cells (GEo) in 7-day C57BL blast colonies initiated either by SCF ({bullet}) or by SCF plus IL-3 ({circ}). Note that only 7 of the 26 colonies contained both types of eosinophil progenitor cells.

 

    DISCUSSION
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
From the clonal culture of murine bone marrow cells and gene inactivation studies, only three myeloid growth factors have been recognized to have proliferative actions on eosinophil precursors—GM-CSF, IL-5, and IL-3 [1–6]—and there is no evidence for the production of IL-3 in normal adult mice [8]. Mice with inactivation of the gene encoding the ß receptor chain subunit shared in common by GM-CSF and IL-5 (ßc-/- mice) show a marked reduction in circulating and marrow eosinophils as expected from these considerations, but residual eosinophil formation does occur in ßc-/- mice [5]. Similarly, mice with inactivation of the ßc gene and the IL-3 gene also show some residual eosinophil formation [9]. This indicates that some other factor must exist to stimulate the residual eosinophil formation able to occur in ßc-/- and ßc-/- IL-3-/- mice.

The present studies showed that ßc-/- marrow contains near-normal levels of eosinophil progenitor cells, but use of ßc-/- marrow cells as target cells failed to detect novel eosinophil colony-stimulating activity in a wide range of media conditioned by cell lines or organs from adult mice, including organs from ßc-/- mice.

Testing of known growth factors on ßc-/- marrow cells showed that SCF had a previously unrecognized capacity to stimulate the formation of small numbers of eosinophilcontaining colonies. This action of SCF was not restricted to ßc-/- cells, and comparable activity was observed with marrow cells from a range of mouse strains and cells from fetal liver and neonatal bone marrow. The eosinophil-stimulating action of SCF was consistently enhanced by combination with G-CSF.

The eosinophil stimulating action in vitro of SCF was weak compared with GM-CSF or multi-CSF, both in terms of eosinophil colony numbers and eosinophils per colony. However, previous experience with agents such as GM-CSF and G-CSF has shown that relative activities in vitro do not necessarily correlate with strength of action in vivo [19]. Moreover, the secreted form of SCF (as used in the present studies) is known to be less efficient than the membrane-displayed form in stimulating hematopoiesis [20]. Thus, the action of SCF on eosinophil formation may be stronger in vivo than evident from the present in vitro studies.

It has yet to be established that all lineage-committed progenitor cells originate from the preprogenitor (blast colony-forming cell) progeny of stem cells [21]. Some may be generated directly from stem cells without passing through a preprogenitor cell stage. This uncertainty aside, the present experiments showed that SCF-responsive preprogenitor cells can form both Eo and GEo progenitor cells. Thus, SCF has the ability not only to stimulate the generation of eosinophil progenitor cells but also to stimulate at least some of these to form mature eosinophils. In these actions, IL-3 has a strong synergistic action on eosinophil progenitor cell formation, and G-CSF a comparable action on the proliferation of the eosinophil progenitor cells.

The present study showed that G-CSF and IL-5 could not act synergistically on committed eosinophil progenitors, extending an earlier study by Yamaguchi et al. [3], although this earlier study did detect an interaction when the two factors were acting on less mature cells.

The blast colony recloning data showed that some Eo and GEo progenitors have the same ancestral preprogenitor cells but did not eliminate the possibility that others might have a different and unrelated ancestral origin.

The SCF-responsive Eo and GEo progenitors may well also be responsive to proliferative stimulation by GM-CSF or IL-3, but the present data indicate that at least most GEo progenitors are unresponsive to IL-5.

It remains for future studies to determine whether there are any functional differences between eosinophils generated from Eo and GEo progenitors.

The present studies have added SCF, acting alone or in combination with G-CSF, to the known factors able to stimulate eosinophil proliferation.

In early studies on the marrow of anemic W/Wv mice that lack functional receptors for SCF, a depleted content of marrow eosinophils was recorded but not commented upon [22]. It will require cross-mating of ßc-/- IL-3-/- mice with either W/Wv or Sld mice that are unable to respond to or produce SCF to establish whether the combined loss of stimulation by GM-CSF, IL-5, IL-3, and SCF leads to an absolute failure of all eosinophil formations. If not, then yet another growth factor must exist with an eosinophil-stimulating action in vivo.


    ACKNOWLEDGMENT
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This work was supported by the Carden Fellowship Fund of the Anti-Cancer Council of Victoria, the National Health and Medical Research Council, Canberra, the Cooperative Research Centre for Cellular Growth Factors, and the National Institutes of Health, Bethesda, MD, Grant No CA22556.

The authors are indebted to the AMRAD Corporation, Melbourne, for making available samples of culture media from their battery of normal and neoplastic murine cell lines.


    REFERENCES
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Metcalf D, Begley CG, Nicola NA et al. Quantitative responsiveness of murine hemopoietic populations in vitro and in vivo to recombinant multi-CSF (IL-3). Exp Hematol 1987;15:288–295.[Medline]

  2. Metcalf D, Burgess AW, Johnson GR et al. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF. J Cell Physiol 1986;128:421–431.[CrossRef][Medline]

  3. Yamaguchi Y, Suda T, Suda J et al. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988;167:43–56.[Abstract/Free Full Text]

  4. Stanley E, Lieschke GJ, Grail D et al. Granulocyte macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994;91:5592–5596.[Abstract/Free Full Text]

  5. Robb L, Drinkwater CC, Metcalf D et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common ß subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci USA 1995;92:9565–9569.[Abstract/Free Full Text]

  6. Mould AW, Matthaei KI, Young IG et al. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997;99:1064–1071.[Medline]

  7. Nicola NA, Robb L, Metcalf D et al. Functional inactivation in mice of the gene for the interleukin-3 (IL-3)-specific receptor ß-chain: implications for IL-3 function and the mechanism of receptor transmodulation in hematopoietic cells. Blood 1996;87:2665–2674.[Abstract/Free Full Text]

  8. Metcalf D, Willson TA, Hilton DJ et al. Production of hematopoietic regulatory factors in cultures of adult and fetal mouse organs: measurement by specific bioassays. Leukemia 1995;9:1556–1564.[Medline]

  9. Nishinakamura R, Miyajima A, Mee PJ et al. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 1996;88:2458–2464.[Abstract/Free Full Text]

  10. Johnson GR, Metcalf D. Detection of a new type of mouse eosinophil colony by Luxol-fast-blue staining. Exp Hematol 1980;8:549–561.[Medline]

  11. Metcalf D. The Hemopoietic Colony Stimulating Factors. Amsterdam: Elsevier Science Publishers, 1984;1-493.

  12. Metcalf D, Alexander WS, Ryan PJ et al. Production of colony-stimulating factors and IL-5 by organs from three types of mice with inflammatory disease due to loss of the suppressor of cytokine signaling-1. J Immunol 2001;167:4661–4667.[Abstract/Free Full Text]

  13. Metcalf D, Willson T, Rossner M et al. Receptor insertion into factor-dependent murine cell lines to develop specific bioassays for murine G-CSF and M-CSF and human GM-CSF. Growth Factors 1994;11:145–152.[Medline]

  14. Begg SK, Radley JM, Pollard JW et al. Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med 1993;177:237–242.[Abstract/Free Full Text]

  15. Metcalf D, Nicola NA. Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: effects of combination with colony-stimulating factors. Proc Natl Acad Sci USA 1991;88:6239–6243.[Abstract/Free Full Text]

  16. Metcalf D. Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony-stimulating factors. Proc Natl Acad Sci USA 1991;88:11310–11314.[Abstract/Free Full Text]

  17. Metcalf D. The cellular basis for enhancement interactions between stem cell factor and the colony stimulating factors. STEM CELLS 1993;11(suppl 2):1–11.

  18. Metcalf D. Lineage commitment in the progeny of murine hematopoietic preprogenitor cells: influence of thrombopoietin and interleukin 5. Proc Natl Acad Sci USA 1998;95:6408–6412.[Abstract/Free Full Text]

  19. Metcalf D, Nicola NA. The Hemopoietic Colony-Stimulating Factors. Cambridge, UK: Cambridge University Press, 1995;1-327.

  20. Toksoz D, Zsebo KM, Smith KA et al. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 1992;89:7350–7354.[Abstract/Free Full Text]

  21. Metcalf D. Stem cells, pre-progenitor cells and lineage-committed cells: are our dogmas correct? Ann N Y Acad Sci 1999;872:289–303.[CrossRef][Medline]

  22. Chervenick PA, Boggs DR. Decreased neutrophils and megakaryocytes in anemic mice of genotype W/Wv. J Cell Physiol 1969;73:25–30.[CrossRef][Medline]

Received May 7, 2002; accepted for publication May 8, 2002.



This article has been cited by other articles:


Home page
J. Immunol.Home page
K. D. Dyer, J. M. Moser, M. Czapiga, S. J. Siegel, C. M. Percopo, and H. F. Rosenberg
Functionally Competent Eosinophils Differentiated Ex Vivo in High Purity from Normal Mouse Bone Marrow
J. Immunol., September 15, 2008; 181(6): 4004 - 4009.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. J. Sinnamon, K. J. Carter, L. P. Sims, B. LaFleur, B. Fingleton, and L. M. Matrisian
A protective role of mast cells in intestinal tumorigenesis
Carcinogenesis, April 1, 2008; 29(4): 880 - 886.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metcalf, D.
Right arrow Articles by Di Rago, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metcalf, D.
Right arrow Articles by Di Rago, L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS